AFEYAN NOUBAR bought GENB

March 2, 2026 · Form 4 insider transaction

AFEYAN NOUBAR bought 1,562,500 shares of Generate Biomedicines, Inc. at $16.00 per share, a transaction worth $25.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,562,500
Price
$16.00
Total value
$25.00M
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 2, 2026
Filing dateMarch 2, 2026
Shares owned after15,264,724
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Securities held by Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII"). Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering is the manager of Flagship Fund VII GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

View the original Form 4 on SEC EDGAR
AFEYAN NOUBAR bought GENB: March 2, 2026 | Insider Trading Screener